Overview

A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival

Status:
Recruiting

Trial end date:
2024-07-01

Target enrollment:

Participant gender:

Summary

The investigators would like to compare the progression free survival, overall survival, quality of life, and safety outcomes of patients receiving versus not receiving a 2nd transurethral resection of bladder tumor.

Phase:

Early Phase 1

Details

Lead Sponsor:

University Health Network, Toronto

Collaborators:

Bladder Cancer Canada
Canadian Urologic Oncology Group
Canadian Urological Association
Canadian Urological Association Scholarship Fund
Canadian Urological Oncology Group